Ask AI

Optimizing Integration of Bispecific Antibody Therapy to Improve Clinical Outcomes in Patients With Multiple Myeloma

Downloadable slides on optimizing the integration of bispecific antibody therapy in multiple myeloma, with a focus on emerging clinical data, patient selection, sequencing, and personalization of treatment. Toxicity management, step-up dosing, outpatient care, and multidisciplinary strategies for safe and effective implementation are also reviewed.

Integration of BsAb Therapy

Activity Information

Released: August 13, 2026